New York, USA, March 04, 2025 (GLOBE NEWSWIRE) -- Dopamine Receptor Antagonists Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Dopamine Receptor Antagonists Therapeutics ...

New research identifies a promising strategy for correcting dopamine imbalances in the brain using a drug that blocks kappa ...

During the double-blind withdrawal period, 41.9% of ecopipam-treated patients relapsed compared with 68.1% of placebo-treated patients. Topline data were announced from a phase 3 trial evaluating ...

Researchers have discovered distinct roles for two dopamine receptors located on nerve cells within the portion of the brain that controls approach vs. avoidance behavior. Mount Sinai researchers ...

Now, new research suggests the drug’s effectiveness is less about the amount of dopamine it produces and more about the number and type of receptors that respond to it. Conditions where a person ...